{"schema_version":"secwatch.filing_event.v1","accession":"0001641489-25-000038","form_type":"8-K","ticker":"VTVT","cik":"0001641489","company_name":"vTv Therapeutics Inc.","filed_at":"2025-06-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.171601+00:00","generated_at":"2026-05-19T10:43:07.182517+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"vTv Therapeutics stockholders elect seven directors and ratify Ernst & Young as auditor for 2025","bullets":["All seven director nominees elected: Srinivas Akkaraju, Raymond Cheong, Fahed Al Marzooqi, Richard S. Nelson, Anne Phillips, Paul Sekhri, Daniel K. Spiegelman.","Votes for director nominees ranged from 2.07M to 2.18M shares; broker non-votes of 219,013 on each.","Ratification of Ernst & Young as independent auditor: 2,400,291 For, 3,852 Against, 1,416 Abstain, 0 broker non-votes."],"urls":{"canonical":"https://secwatch.observer/filing/0001641489-25-000038","json":"https://secwatch.observer/filing/0001641489-25-000038.json","markdown":"https://secwatch.observer/filing/0001641489-25-000038.md","text":"https://secwatch.observer/filing/0001641489-25-000038.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1641489/000164148925000038/0001641489-25-000038-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1641489/000164148925000038/vtvt-20250610.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T10:43:07.182517+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}